BASKING RIDGE, N.J., June 12, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, announces its participation in the upcoming GCFF Innovation & Healthcare virtual conference on June…Read More
Lisata Therapeutics to Present at the GCFF Innovation and Healthcare Virtual Conference
